Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

A Pilot Study on Ocular Safety and Efficacy of Infliximab as an Antifibrotic Agent After Experimental Glaucoma Filtration Surgery.

Nikita E, Moulin A, Vergados I, Brouzas D, Theodossiadis PG.

Ophthalmol Ther. 2017 Dec;6(2):323-334. doi: 10.1007/s40123-017-0096-4. Epub 2017 Jul 1.

2.

Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy.

Zarei R, Masoumpour M, Moghimi S, Fakhraei G, Eslami Y, Mohammadi M.

J Curr Ophthalmol. 2016 Dec 27;29(2):85-91. doi: 10.1016/j.joco.2016.10.003. eCollection 2017 Jun.

3.
4.

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.

Andrés-Guerrero V, Perucho-González L, García-Feijoo J, Morales-Fernández L, Saenz-Francés F, Herrero-Vanrell R, Júlvez LP, Llorens VP, Martínez-de-la-Casa JM, Konstas AG.

Adv Ther. 2017 Feb;34(2):378-395. doi: 10.1007/s12325-016-0461-z. Epub 2016 Dec 20. Review.

5.

Intravitreal Injection of Bevacizumab in Primary Vitrectomy to Decrease the Rate of Retinal Redetachment: A Randomized Pilot Study.

Tousi A, Hasanpour H, Soheilian M.

J Ophthalmic Vis Res. 2016 Jul-Sep;11(3):271-6. doi: 10.4103/2008-322X.188390.

6.

Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.

Mahdy RA, Al-Mosallamy SM, Al-Aswad MA, Bor'i A, El-Haig WM.

Eye (Lond). 2016 Jan;30(1):53-8. doi: 10.1038/eye.2015.182. Epub 2015 Oct 2.

7.
8.

Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.

Kim M, Lee C, Payne R, Yue BY, Chang JH, Ying H.

Surv Ophthalmol. 2015 Nov-Dec;60(6):524-35. doi: 10.1016/j.survophthal.2015.04.003. Epub 2015 May 15. Review.

9.

The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report.

Popescu V, Leasu C, Stana D, Alexandrescu C, Dumitrescu A.

J Med Life. 2015 Jan-Mar;8(1):103-5.

10.

Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery.

Xi L, Wang T, Zhao F, Zheng Q, Li X, Luo J, Liu J, Quan D, Ge J.

PLoS One. 2014 Jun 20;9(6):e100632. doi: 10.1371/journal.pone.0100632. eCollection 2014.

11.

Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.

Van Bergen T, Van de Velde S, Vandewalle E, Moons L, Stalmans I.

Clin Ophthalmol. 2014 May 2;8:857-67. doi: 10.2147/OPTH.S48745. eCollection 2014. Review.

12.

The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study.

Peng R, Qin G, Li X, Lv H, Qian Z, Yu L.

Med Hypothesis Discov Innov Ophthalmol. 2014 Spring;3(1):3-8.

13.

Subconjunctival bevacizumab injection in glaucoma filtering surgery: a case control series.

Wang J, Harasymowycz P.

ISRN Ophthalmol. 2013 Mar 14;2013:384134. doi: 10.1155/2013/384134. eCollection 2013.

14.

Risk of scar in the comparison of age-related macular degeneration treatments trials.

Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, Huang J, Ying GS, Hagstrom SA, Winter K, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2014 Mar;121(3):656-66. doi: 10.1016/j.ophtha.2013.10.019. Epub 2013 Dec 4.

15.

Effects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case series.

Klos-Rola J, Tulidowicz-Bielak M, Zarnowski T.

Clin Ophthalmol. 2013;7:1929-35. doi: 10.2147/OPTH.S45210. Epub 2013 Sep 25.

16.

Comparison of trabeculectomy and trabeculectomy with amniotic membrane transplantation in the same patient with bilateral glaucoma.

Ji QS, Qi B, Liu L, Lao W, Yang ZH, Wang GF, Yu GC, Zhong JX.

Int J Ophthalmol. 2013 Aug 18;6(4):448-51. doi: 10.3980/j.issn.2222-3959.2013.04.07. eCollection 2013.

17.

Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy.

Freiberg FJ, Matlach J, Grehn F, Karl S, Klink T.

Clin Ophthalmol. 2013;7:1211-7. doi: 10.2147/OPTH.S41750. Epub 2013 Jun 20.

18.

Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery.

Butler MR, Prospero Ponce CM, Weinstock YE, Orengo-Nania S, Chevez-Barrios P, Frankfort BJ.

Invest Ophthalmol Vis Sci. 2013 Jul 24;54(7):4982-90. doi: 10.1167/iovs.13-12047.

19.

Safety of bevacizumab on extraocular muscle in a rabbit model.

Jung JH, Lee JH, Lee JE, Choi HY.

Korean J Ophthalmol. 2012 Aug;26(4):290-6. doi: 10.3341/kjo.2012.26.4.290. Epub 2012 Jul 24.

20.

Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma.

Sedghipour MR, Mostafaei A, Taghavi Y.

Clin Ophthalmol. 2011;5:797-800. doi: 10.2147/OPTH.S17896. Epub 2011 Jun 15.

Supplemental Content

Support Center